BackGenetics Generation Advancement Overview

Genetics Generation Advancement Intangible Assets

Track Genetics Generation Advancement's intangible assets ($14M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$13.91M
↓ 41.43% YoYΔ $-9.84M vs prior year quarter

Peer trimmed avg / median

Loading

Genetics Generation Advancement Intangible Assets History

Loading

Genetics Generation Advancement vs. peers: Intangible Assets Comparison

Loading

Genetics Generation Advancement Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Genetics Generation Advancement (4160.TWO) FAQ

Genetics Generation Advancement posts a intangible assets of $14M as of June 2026. That compares with $24M in the prior-year period — down 41.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Genetics Generation Advancement's intangible assets was $24M. The latest reading is $14M — a 41.4% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Intangible Assets is one piece of Genetics Generation Advancement's financial statement story. At $14M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 4160.TWO's intangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Genetics Generation Advancement's other metric pages and overview cover the third.